Clinical significance of gastrointestinal bleeding after living donor liver transplantation

Koichi Kimura, Toru Ikegami, Yuki Bekki, Mizuki Ninomiya, Yo Ichi Yamashita, Tomoharu Yoshizumi, Shohei Yoshiya, Yuji Soejima, Noboru Harada, Ken Shirabe, Yoshihiko Maehara

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


The clinical presentations of gastrointestinal bleeding (GIB) occurring after living donor liver transplantation (LDLT) have not been fully described. We performed a retrospective analysis of 297 LDLT cases. Nineteen patients (6.4%) experienced GIB after LDLT. The etiology of GIB included bleeding at the jejunojejunostomy following hepaticojejunostomy (n = 13), peptic ulcer disease (n = 2), portal hypertensive gastropathy (n = 2), and other causes (n = 2). Hemostasis was achieved in 13 patients (68.4%) by endoscopic (n = 3), surgical (n = 1), or supportive treatments (n = 15), but not in the other six patients. Graft dysfunction (P < 0.001), hepaticojejunostomy (P = 0.01), portal vein pressure at the end of surgery >20 mmHg (P = 0.002), and operative blood loss >10 L (P = 0.004) were risk factors. One-year graft survival rate was significantly lower in patients with GIB than in patients without GIB (P < 0.001). The inhospital mortality rate was 52.6% for patients with GIB, 75.0% for patients with graft dysfunction, and 14.3% for patients without graft dysfunction (P = 0.028). Despite its infrequency after LDLT, GIB has strong correlation with graft dysfunction and inhospital mortality.

Original languageEnglish
Pages (from-to)705-711
Number of pages7
JournalTransplant International
Issue number7
Publication statusPublished - Jul 2014

All Science Journal Classification (ASJC) codes

  • Transplantation


Dive into the research topics of 'Clinical significance of gastrointestinal bleeding after living donor liver transplantation'. Together they form a unique fingerprint.

Cite this